Outlook Therapeutics, Inc.

NASDAQ:OTLK

Biotechnology

Healthcare
$0.41 -5.76%

-$0.10 today

Market cap
$99.30M
Beta
0.98
P/E (TTM)
-2.1
EPS (TTM)
-$0.74
52W Low $0.16High $3.39

Volume 4.42M

Average 17.46M

OTLK Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Outlook Therapeutics, Inc.NASDAQ: OTLK

Accounts Payables · Q2 FY2026 · quarter ended Mar 2026

Accounts payables turns positive

Q2 FY2026 accounts payables was $5.71M, compared with -$4.63M a year earlier. Trailing-twelve-month accounts payables was $4.9M. Over 3 fiscal years it compounded at +8.8% a year.

Context

  • Accounts payables amounted to 117.9% of revenue in FY2025.
  • Accounts payables increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly accounts payables holds near $5.71M or moves back toward the trailing-twelve-month quarterly average of $1.23M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$5.71M+298.6% QoQ
Last fiscal yearSep 2025
$1.67M+19.5% YoY
LTMMar 2026
$4.9M+28.5% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+223.3%——
1 year+19.5%——
3-year CAGR+8.8%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
1.67M USD
Year-over-year change
+19.5%

Accounts Payables vs competitors

How OTLK compares with its peers on the latest reported figures

  • OTLK's LTM Mar 2026 accounts payables of $4.9M is the 2nd largest of the 9 companies compared; the peer median is $266.74K.
  • Its year-over-year change of +28.5% is the 5th highest of 9, against a peer median of +22.8%.
  • Accounts payables amounts to 1472.1% of revenue for OTLK, versus a peer median of 5.3%.
OTLK Competitors Peer median
Accounts Payables for OTLK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OSTXOS Therapies IncorporatedLTM Mar 2026$12.2M +1170.0%+236.9%—
OTLKOutlook Therapeutics, Inc.LTM Mar 2026$4.9M +28.5%+8.8%1472.1%
HOWLWerewolf Therapeutics, Inc.LTM Jun 2026$3.45M -438.7%+104.0%16.4%
EQEquillium, Inc.LTM Mar 2026$1.88M -646.1%——
SPRBSpruce Biosciences, Inc.LTM Mar 2026$764K +6466.7%-36.8%—
CUECue Biopharma, Inc.LTM Mar 2026$458K +239.3%+138.4%1.4%
IPSCCentury Therapeutics, Inc.LTM Mar 2026$424K -76.4%——
COEPCoeptis Therapeutics, Inc.LTM Mar 2026$109.49K -55.4%+121.5%7.7%
NRXPNRx Pharmaceuticals, Inc.LTM Mar 2026$64K +100.9%—2.8%
Peer median (excluding OTLK) $266.74K+22.8%+121.5%5.3%

Competitors are the stored peer set for OTLK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Net Income(53.16M)(66.05M)(58.98M)(75.37M)(62.42M)
Depreciation & Amortization262.14K204.69K44.19K113.86K117.05K
Deferred Income Tax498.49K0000
Stock-Based Compensation4.89M7.71M5.55M5.39M8.9M
Change in Working Capital(7.08M)(1.68M)4.75M(3.02M)4.86M
Accounts Receivables0000(1.49M)
Inventory0000(3.34M)
Accounts Payables(198.47K)1.3M3.08M1.39M1.67M
Other Working Capital(6.88M)(2.98M)1.67M(4.41M)8.02M
Other Non-Cash Items341.55K3.15M5.66M4.09M1.58T
Operating Cash Flow(54.25M)(56.67M)(42.97M)(68.79M)(51.83M)
Capital Expenditures0000(3)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow00000
Debt Repayment6.31M(2.32M)19.77M(4.27K)(3.04M)
Common Stock Issued46.3M62.31M30.02M60.33M48.03M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities3.59M(394.15K)(823.89K)044.98T
Financing Cash Flow56.19M59.59M48.97M60.33M44.98M
Effect of Forex Changes00000
Net Change in Cash1.94M2.92M6M(8.46M)(6.84M)
Free Cash Flow(54.25M)(56.67M)(42.97M)(68.79M)(51.83M)

Outlook Therapeutics, Inc.

NASDAQ:OTLK

Intrinsic Alpha fair value

Locked

Current Price

$0.41

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.